are glp 1 good for you GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Weight Loss Blog – Maryland

100 A recent Phase 2b trial in obese individuals demonstrated that 32 weeks of treatment with danuglipron at doses ranging from 40 to 200 mg twice daily resulted in an average weight loss of 11.7%, whereas the placebo group exhibited 1.4% weight gain

Healing time reductions of 30 to 50% have been documented across various wound types

Hepatitis C

11 [corrected] Screening The American Diabetes Association Diabetes Standards of Care guidelines recommend diabetic peripheral neuropathy screening with monofilament testing, but this practice has poor sensitivity for detecting peripheral neuropathy

Thus, careful monitoring during the first weeks of GLP-1 therapy is critical

This finding could pave the way for more targeted treatments that go beyond blood sugar management to directly address kidney deterioration and cardiovascular risks in diabetes